Búsqueda | Portal de Búsqueda de la BVS

1.

Are current guidelines adapted for patient eligibility to PrEP? A case report.

Van Obberghen, Elise K; Viard, Delphine; Lafeuillade, Alain; Civiletti, Alexandre; Rocher, Fanny; Drici, Milou-Daniel.

BMC Infect Dis ; 19(1): 601, 2019 Jul 10.

Artículo en Inglés | MEDLINE | ID: mdl-31291899

2.

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.

de Castro, Nathalie; Braun, Joséphine; Charreau, Isabelle; Lafeuillade, Alain; Viard, Jean-Paul; Allavena, Clotilde; Aboulker, Jean-Pierre; Molina, Jean-Michel.

AIDS Res Ther ; 13: 17, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-27042193

3.

Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial.

Lafeuillade, Alain; Assi, Assi; Poggi, Cécile; Bresson-Cuquemelle, Caroline; Jullian, Eric; Tamalet, Catherine.

AIDS Res Ther ; 11(1): 33, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25320633

4.

Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.

Lafeuillade, Alain; Wainberg, Mark; Gougeon, Marie-Lise; Loes, Sabine Kinloch-de; Halfon, Philippe; Tissot-Dupont, Hervé.

AIDS Res Ther ; 11: 28, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25165483

5.

Eliminating the HIV reservoir.

Lafeuillade, Alain.

Curr HIV/AIDS Rep ; 9(2): 121-31, 2012 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-22415474

6.

Conference highlights of the 5th international workshop on HIV persistence during therapy, 6-9 December 2011, St. Maartin, West Indies.

Stevenson, Mario; Chomont, Nicolas; Lafeuillade, Alain.

AIDS Res Ther ; 9(1): 7, 2012 Mar 12.

Artículo en Inglés | MEDLINE | ID: mdl-22409770

7.

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.

Lafeuillade, Alain; Soriano, Vicente; Suzan-Monti, Marie; Stevenson, Mario; Izopet, Jacques; Stellbrink, Hans-Jürgen.

AIDS Res Ther ; 9(1): 23, 2012 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-22853692

8.

Potential strategies for an HIV infection cure.

Lafeuillade, Alain.

HIV Clin Trials ; 12(3): 121-30, 2011.

Artículo en Inglés | MEDLINE | ID: mdl-21684852

9.

Rectal cell-associated HIV-1 RNA: a new marker ready for the clinic.

Lafeuillade, Alain; Cheret, Antoine; Hittinger, Gilles; Bernardini, David; Cuquemelle, Caroline; Jullian, Eric; Poggi, Cécile.

HIV Clin Trials ; 10(5): 324-7, 2009.

Artículo en Inglés | MEDLINE | ID: mdl-19906625

10.

Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.

Haubrich, Richard; Soriano, Vincent; Lafeuillade, Alain.

HIV Clin Trials ; 9(5): 348-65, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-18977724

11.

Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.

Solas, Caroline; Gagnieu, Marie-Claude; Ravaux, Isabelle; Drogoul, Marie-Pierre; Lafeuillade, Alain; Mokhtari, Saadia; Lacarelle, Bruno; Simon, Nicolas.

Ther Drug Monit ; 30(6): 670-3, 2008 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-18806695

12.

Highlights from the 8^th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.

Psomas, Christina K; Lafeuillade, Alain; Margolis, David; Salzwedel, Karl; Stevenson, Mario; Chomont, Nicolas; Poli, Guido; Routy, Jean-Pierre.

J Virus Erad ; 4(2): 132-142, 2018 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-29682308

13.

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.

Psomas, Christina; Kinloch, Sabine; Sabin, Caroline; Soriano, Vicente; Solas, Caroline; Orkin, Chloe; Bernardino, José; Curran, Adrian; Routy, Jean-Pierre; Enel, Patricia; Philibert, Patrick; Lafeuillade, Alain.

J Virus Erad ; 4(3): 196-207, 2018 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-30050686

14.

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.

Lacombe, Karine; Fontaine, Hélène; Dhiver, Catherine; Metivier, Sophie; Rosenthal, Eric; Antonini, Teresa; Valantin, Marc Antoine; Miailhes, Patrick; Harent, Stanislas; Batisse, Dominique; Pageaux, Georges-Philippe; Chas, Julie; Aumaitre, Hugues; Dominguez, Stephanie; Allegre, Thierry; Lafeuillade, Alain; Billaud, Eric; De Truchis, Pierre; Perre, Philippe; Leroy, Vincent; De Ledinghen, Victor; Sogni, Philippe; Dabis, François; Zhao, Yue; Filipovics, Anne; Fedchuk, Larysa; Akremi, Raoudha; Bennai, Yacia; Salmon Ceron, Dominique.

J Acquir Immune Defic Syndr ; 75(1): 97-107, 2017 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-28272163

15.

[A new road map for eradication of HIV]. / Une nouvelle feuille de route pour l'éradication du VIH.

Lafeuillade, Alain.

Med Trop (Mars) ; 71(3): 213-4, 2011 Jun.

Artículo en Francés | MEDLINE | ID: mdl-21870540

16.

Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USA.

Margolis, David M; Salzwedel, Karl; Chomont, Nicolas; Psomas, Christina; Routy, Jean-Pierre; Poli, Guido; Lafeuillade, Alain.

J Virus Erad ; 2(1): 57-65, 2016 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-27482437

17.

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.

Routy, Jean-Pierre; Psomas, Christina; Soriano, Vicente; Philibert, Patrick; Tissot-Dupont, Hervé; Lafeuillade, Alain.

J Virus Erad ; 2(3): 187-92, 2016 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-27482461

18.

Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review.

Lafeuillade, Alain; Tardy, Jean-Claude.

AIDS Rev ; 5(2): 80-6, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12876897

19.

Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10-13 December 2019, Miami, USA.

Psomas, Christina K; Salzwedel, Karl; Stevenson, Mario; Poli, Guido; Routy, Jean-Pierre; Margolis, David; Chomont, Nicolas; Lafeuillade, Alain.

J Virus Erad ; 6(2): 85-95, 2020 Apr 30.

Artículo en Inglés | MEDLINE | ID: mdl-32405427

20.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

Chéret, Antoine; Nembot, Georges; Mélard, Adeline; Lascoux, Caroline; Slama, Laurence; Miailhes, Patrick; Yeni, Patrick; Abel, Sylvie; Avettand-Fenoel, Véronique; Venet, Alain; Chaix, Marie-Laure; Molina, Jean-Michel; Katlama, Christine; Goujard, Cécile; Tamalet, Catherine; Raffi, François; Lafeuillade, Alain; Reynes, Jacques; Ravaux, Isabelle; Hoën, Bruno; Delfraissy, Jean-François; Meyer, Laurence; Rouzioux, Christine.

Lancet Infect Dis ; 15(4): 387-96, 2015 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-25701561

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Are current guidelines adapted for patient eligibility to PrEP? A case report.

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.

Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial.

Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.

Eliminating the HIV reservoir.

Conference highlights of the 5th international workshop on HIV persistence during therapy, 6-9 December 2011, St. Maartin, West Indies.

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.

Potential strategies for an HIV infection cure.

Rectal cell-associated HIV-1 RNA: a new marker ready for the clinic.

Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.

Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.

Highlights from the 8^th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.

[A new road map for eradication of HIV]. / Une nouvelle feuille de route pour l'éradication du VIH.

Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USA.

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.

Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review.

Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10-13 December 2019, Miami, USA.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.